Oracle Health Sciences Data Management Workbench 2.5.2.1/3.0.0.0 User Interface deserialization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.1 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, was found in Oracle Health Sciences Data Management Workbench 2.5.2.1/3.0.0.0. This vulnerability affects unknown code of the component User Interface. Such manipulation leads to an unknown weakness. This vulnerability is documented as CVE-2019-10086. The attack can be executed remotely. There is not any exploit available. You should upgrade the affected component.
Details
A vulnerability was found in Oracle Health Sciences Data Management Workbench 2.5.2.1/3.0.0.0 (Medical Device Software). It has been rated as critical. Affected by this issue is some unknown functionality of the component User Interface. Using CWE to declare the problem leads to CWE-502. The product deserializes untrusted data without sufficiently verifying that the resulting data will be valid. Impacted is confidentiality, integrity, and availability.
The weakness was released 07/19/2022 as Oracle Critical Patch Update Advisory - July 2022. The advisory is shared for download at oracle.com. This vulnerability is handled as CVE-2019-10086. There are neither technical details nor an exploit publicly available.
The vulnerability scanner Nessus provides a plugin with the ID 210560 (RHEL 8 : RHV Manager (ovirt-engine) 4.4 (RHSA-2020:3247)), which helps to determine the existence of the flaw in a target environment.
Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at Tenable (210560) and CERT Bund (WID-SEC-2022-0770). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Affected
- IBM DB2
- Red Hat Enterprise Linux
- IBM SPSS
- EMC Avamar
- Hitachi Ops Center
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.3VulDB Meta Temp Score: 7.1
VulDB Base Score: 7.3
VulDB Temp Score: 7.0
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.3
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: DeserializationCWE: CWE-502 / CWE-20
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 210560
Nessus Name: RHEL 8 : RHV Manager (ovirt-engine) 4.4 (RHSA-2020:3247)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Timeline
03/26/2019 🔍07/19/2022 🔍
07/19/2022 🔍
07/20/2022 🔍
01/11/2026 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - July 2022
Status: Confirmed
CVE: CVE-2019-10086 (🔍)
GCVE (CVE): GCVE-0-2019-10086
GCVE (VulDB): GCVE-100-204416
CERT Bund: WID-SEC-2022-0770 - IBM DB2: Mehrere Schwachstellen
Entry
Created: 07/20/2022 08:16Updated: 01/11/2026 19:41
Changes: 07/20/2022 08:16 (39), 08/13/2022 21:09 (2), 08/13/2022 21:22 (19), 11/09/2024 20:03 (16), 01/11/2026 19:41 (7)
Complete: 🔍
Cache ID: 216:3F0:103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.